Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/22/26 16:10 | 9/18/26 | PSNL | Health | Health | Medical Laboratories | Moore Stephen Michael | CA | O | SVP,GC | 1 | S | -34 | 16.22 | 0 | -2 | 90 | D | |||||||||||||||
9/22/26 16:10 | 9/18/26 | PSNL | Health | Health | Medical Laboratories | Chen Richard | CA | O | P,CMO | 3 | S.d | -1,583 | 15.15 | 0 | -104 | 174 | D | |||||||||||||||
9/22/26 16:10 | 9/18/26 | PSNL | Health | Health | Medical Laboratories | Hall Christopher M | CA | DO | CEO | 5 | S.dm | -4,312 | 12.79 | 0 | -337 | 236 | D | |||||||||||||||
9/22/26 16:10 | 7/28/25 | PSNL | Health | Health | Medical Laboratories | Tachibana Aaron | CA | O | CFO,COO | 8 | S.d | -2,858 | 11.74 | 0 | -243 | 199 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |